Hariom Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 03-12-2024
- Paid Up Capital ₹ 3.75 M
as on 03-12-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 12.60 Cr
as on 03-12-2024
About Hariom Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.75 M.
The company has closed loans amounting to ₹12.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pradeepkumar Goyal, Rishi Goyal, Rajkumar Goyal, and One other member serve as directors at the Company.
- CIN/LLPIN
U15135MH2005PTC157063
- Company No.
157063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hariom Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeepkumar Goyal  | Director | 26-Oct-2005 | Current |
| Rishi Goyal | Director | 21-Jun-2007 | Current |
| Rajkumar Goyal | Director | 21-Jun-2007 | Current |
| Anurag Goyal | Director | 01-Jun-2009 | Current |
Financial Performance of Hariom Biotech.
Hariom Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hariom Biotech?
In 2017, Hariom Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹0
₹126.00 M
Charges Breakdown by Lending Institutions
- Others : 6.00 Cr
- State Bank Of India Itwari Branch (00518) : 3.90 Cr
- State Bank Of India : 2.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2016 | Others | ₹6.00 Cr | Satisfied |
| 31 Mar 2013 | State Bank Of India | ₹1.35 Cr | Satisfied |
| 25 Sep 2012 | State Bank Of India | ₹1.35 Cr | Satisfied |
| 16 Oct 2007 | State Bank Of India Itwari Branch (00518) | ₹1.95 Cr | Satisfied |
| 16 Oct 2007 | State Bank Of India Itwari Branch (00518) | ₹1.95 Cr | Satisfied |
How Many Employees Work at Hariom Biotech?
Unlock and access historical data on people associated with Hariom Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hariom Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hariom Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
